NYXH Nyxoah SA
$1.69 -14.21%
Updated
Healthcare · Surgical & Medical Instruments & Apparatus
Nyxoah SA (NYXH) is a healthcare company in the Surgical & Medical Instruments & Apparatus industry. Shares last traded at $1.69, 75.1% below their 52-week high. Over the past year the stock is down 73.3%.
Market Cap
—
Shares Out
—
EPS (TTM)
—
P/E Ratio
—
P/S Ratio
—
P/B Ratio
—
Dividend / Share
—
Dividend Yield
—
52-Week High
$6.80
52-Week Low
$1.21
Volume
77,883
Avg Vol (3m)
12,564.238
Performance
1W
+6.96%
1M
+20.28%
3M
-41.32%
6M
-58.12%
YTD
-62.53%
1Y
-73.30%
Chart
Full chart →Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.
Technicals
RSI (14)
53.58
SMA (50)
$1.58
SMA (200)
$3.23
Price vs SMA50
+7.09%
Price vs SMA200
-47.76%
ATR (14)
$0.12
Surgical & Medical Instruments & Apparatus peers
NYXH vs 14 industry peers (Surgical & Medical Instruments & Apparatus), by market cap. Updated
1–14 of 14
| SYK | Stryker Corporation | $118.2B | 31.69 | 4.57 | 14.4% | -1.31% |
| MMM | 3M | $86.8B | 28.97 | 3.45 | 11.9% | -0.28% |
| BSX | Boston Scientific | $68.0B | 18.54 | 3.24 | 17.5% | -3.17% |
| BDX | Becton Dickinson | $51.1B | 54.30 | 2.45 | 4.5% | +0.00% |
| DXCM | DexCom | $33.9B | 33.86 | 6.81 | 20.1% | +0.02% |
| RMD | ResMed | $33.1B | 21.70 | 5.85 | 26.9% | -0.78% |
| MDLN | Medline Inc. | $30.7B | — | 1.08 | — | +0.88% |
| WST | West Pharmaceutical Services | $24.1B | 42.67 | 7.25 | 17.0% | +0.00% |
| SOLV | Solventum | $15.7B | 10.97 | 1.89 | 17.3% | +0.56% |
| BAX | Baxter International | $13.2B | -12.44 | 1.15 | -9.3% | -0.51% |
| PEN | Penumbra Inc | $12.7B | 78.81 | 9.02 | 11.4% | -0.46% |
| GKOS | Glaukos Corp | $10.6B | -56.59 | 17.36 | -30.7% | +0.52% |
| GMED | Globus Medical Inc | $10.5B | 19.59 | 3.34 | 17.0% | -3.14% |
| PODD | Insulet Corporation | $10.4B | 27.82 | 3.42 | 12.3% | +1.63% |
Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.